Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions

K. S. Chae, M. J. Kang, J. H. Lee, B. K. Ryu, M. G. Lee, N. G. Her, T. K. Ha, J. Han, Yoon Ki Kim, Sung-Gil Chi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Transforming growth factor (TGF)-Β1 has biphasic functions in prostate tumorigenesis, having a growth-inhibitory effect in the early stages, but in the late stages promoting tumor angiogenesis and metastasis. We demonstrate here that tumor-producing TGF-Β1 induces vascular endothelial growth factor (VEGF) in prostate cancer cells, and hypoxia-inducible factor (HIF)-1α and HIF-2α has opposite functions in TGF-Β1 regulation of VEGF expression under non-hypoxic conditions. The promoter response of VEGF to TGF-Β1 was upregulated by the transfection of HIF-2α or siHIF-1α but downregulated by HIF-1α and siHIF-2α. Both HIF-1α and HIF-2α were induced by TGF-Β1 at mRNA and protein levels, however, their nuclear translocation was differentially regulated by TGF-Β1, suggesting its association with their opposite effects. VEGF induction by TGF-Β1 occurred in a Smad3-dependent manner, and the Smad-binding element 2 (SBE2, 992 to 986) and hypoxia response element (975 to 968) in the VEGF promoter were required for the promoter response to TGF-Β1. Smad3 cooperated with HIF-2α in TGF-Β1 activation of VEGF transcription and Smad3 binding to the SBE2 site was greatly impaired by knockdown of HIF-2α expression. Moreover, the VEGF promoter response to TGF-Β1 was synergistically elevated by co-transfection of Smad3 and HIF-2α but attenuated by HIF-1α in a dose-dependent manner. Additionally, TGF-Β1 was found to increase the stability of VEGF transcript by facilitating the cytoplasmic translocation of a RNA-stabilizing factor HuR. Collectively, our data show that tumor-producing TGF-Β1 induces VEGF at the both transcription and post-transcriptional levels through multiple routes including Smad3, HIF-2α and HuR. This study thus suggests that autocrine TGF-Β1 production may contribute to tumor angiogenesis via HIF-2α signaling under non-hypoxic conditions, providing a selective growth advantage for prostate tumor cells.

Original languageEnglish
Pages (from-to)1213-1228
Number of pages16
JournalOncogene
Volume30
Issue number10
DOIs
Publication statusPublished - 2011 Mar 10

Fingerprint

Transforming Growth Factors
Vascular Endothelial Growth Factor A
Protein Isoforms
Hypoxia-Inducible Factor 1
Neoplasms
Hypoxia
Transfection
Prostate
Cell Hypoxia
endothelial PAS domain-containing protein 1
Response Elements
Growth
Prostatic Neoplasms
Carcinogenesis
Down-Regulation
RNA

Keywords

  • HIF-2α
  • HuR
  • prostate cancer
  • Smad3
  • TGF-β1
  • VEGF

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Chae, K. S., Kang, M. J., Lee, J. H., Ryu, B. K., Lee, M. G., Her, N. G., ... Chi, S-G. (2011). Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions. Oncogene, 30(10), 1213-1228. https://doi.org/10.1038/onc.2010.498

Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions. / Chae, K. S.; Kang, M. J.; Lee, J. H.; Ryu, B. K.; Lee, M. G.; Her, N. G.; Ha, T. K.; Han, J.; Kim, Yoon Ki; Chi, Sung-Gil.

In: Oncogene, Vol. 30, No. 10, 10.03.2011, p. 1213-1228.

Research output: Contribution to journalArticle

Chae, KS, Kang, MJ, Lee, JH, Ryu, BK, Lee, MG, Her, NG, Ha, TK, Han, J, Kim, YK & Chi, S-G 2011, 'Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions', Oncogene, vol. 30, no. 10, pp. 1213-1228. https://doi.org/10.1038/onc.2010.498
Chae, K. S. ; Kang, M. J. ; Lee, J. H. ; Ryu, B. K. ; Lee, M. G. ; Her, N. G. ; Ha, T. K. ; Han, J. ; Kim, Yoon Ki ; Chi, Sung-Gil. / Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions. In: Oncogene. 2011 ; Vol. 30, No. 10. pp. 1213-1228.
@article{bc0577d337c345b69501717b21bbde05,
title = "Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions",
abstract = "Transforming growth factor (TGF)-Β1 has biphasic functions in prostate tumorigenesis, having a growth-inhibitory effect in the early stages, but in the late stages promoting tumor angiogenesis and metastasis. We demonstrate here that tumor-producing TGF-Β1 induces vascular endothelial growth factor (VEGF) in prostate cancer cells, and hypoxia-inducible factor (HIF)-1α and HIF-2α has opposite functions in TGF-Β1 regulation of VEGF expression under non-hypoxic conditions. The promoter response of VEGF to TGF-Β1 was upregulated by the transfection of HIF-2α or siHIF-1α but downregulated by HIF-1α and siHIF-2α. Both HIF-1α and HIF-2α were induced by TGF-Β1 at mRNA and protein levels, however, their nuclear translocation was differentially regulated by TGF-Β1, suggesting its association with their opposite effects. VEGF induction by TGF-Β1 occurred in a Smad3-dependent manner, and the Smad-binding element 2 (SBE2, 992 to 986) and hypoxia response element (975 to 968) in the VEGF promoter were required for the promoter response to TGF-Β1. Smad3 cooperated with HIF-2α in TGF-Β1 activation of VEGF transcription and Smad3 binding to the SBE2 site was greatly impaired by knockdown of HIF-2α expression. Moreover, the VEGF promoter response to TGF-Β1 was synergistically elevated by co-transfection of Smad3 and HIF-2α but attenuated by HIF-1α in a dose-dependent manner. Additionally, TGF-Β1 was found to increase the stability of VEGF transcript by facilitating the cytoplasmic translocation of a RNA-stabilizing factor HuR. Collectively, our data show that tumor-producing TGF-Β1 induces VEGF at the both transcription and post-transcriptional levels through multiple routes including Smad3, HIF-2α and HuR. This study thus suggests that autocrine TGF-Β1 production may contribute to tumor angiogenesis via HIF-2α signaling under non-hypoxic conditions, providing a selective growth advantage for prostate tumor cells.",
keywords = "HIF-2α, HuR, prostate cancer, Smad3, TGF-β1, VEGF",
author = "Chae, {K. S.} and Kang, {M. J.} and Lee, {J. H.} and Ryu, {B. K.} and Lee, {M. G.} and Her, {N. G.} and Ha, {T. K.} and J. Han and Kim, {Yoon Ki} and Sung-Gil Chi",
year = "2011",
month = "3",
day = "10",
doi = "10.1038/onc.2010.498",
language = "English",
volume = "30",
pages = "1213--1228",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Opposite functions of HIF-α isoforms in VEGF induction by TGF-Β1 under non-hypoxic conditions

AU - Chae, K. S.

AU - Kang, M. J.

AU - Lee, J. H.

AU - Ryu, B. K.

AU - Lee, M. G.

AU - Her, N. G.

AU - Ha, T. K.

AU - Han, J.

AU - Kim, Yoon Ki

AU - Chi, Sung-Gil

PY - 2011/3/10

Y1 - 2011/3/10

N2 - Transforming growth factor (TGF)-Β1 has biphasic functions in prostate tumorigenesis, having a growth-inhibitory effect in the early stages, but in the late stages promoting tumor angiogenesis and metastasis. We demonstrate here that tumor-producing TGF-Β1 induces vascular endothelial growth factor (VEGF) in prostate cancer cells, and hypoxia-inducible factor (HIF)-1α and HIF-2α has opposite functions in TGF-Β1 regulation of VEGF expression under non-hypoxic conditions. The promoter response of VEGF to TGF-Β1 was upregulated by the transfection of HIF-2α or siHIF-1α but downregulated by HIF-1α and siHIF-2α. Both HIF-1α and HIF-2α were induced by TGF-Β1 at mRNA and protein levels, however, their nuclear translocation was differentially regulated by TGF-Β1, suggesting its association with their opposite effects. VEGF induction by TGF-Β1 occurred in a Smad3-dependent manner, and the Smad-binding element 2 (SBE2, 992 to 986) and hypoxia response element (975 to 968) in the VEGF promoter were required for the promoter response to TGF-Β1. Smad3 cooperated with HIF-2α in TGF-Β1 activation of VEGF transcription and Smad3 binding to the SBE2 site was greatly impaired by knockdown of HIF-2α expression. Moreover, the VEGF promoter response to TGF-Β1 was synergistically elevated by co-transfection of Smad3 and HIF-2α but attenuated by HIF-1α in a dose-dependent manner. Additionally, TGF-Β1 was found to increase the stability of VEGF transcript by facilitating the cytoplasmic translocation of a RNA-stabilizing factor HuR. Collectively, our data show that tumor-producing TGF-Β1 induces VEGF at the both transcription and post-transcriptional levels through multiple routes including Smad3, HIF-2α and HuR. This study thus suggests that autocrine TGF-Β1 production may contribute to tumor angiogenesis via HIF-2α signaling under non-hypoxic conditions, providing a selective growth advantage for prostate tumor cells.

AB - Transforming growth factor (TGF)-Β1 has biphasic functions in prostate tumorigenesis, having a growth-inhibitory effect in the early stages, but in the late stages promoting tumor angiogenesis and metastasis. We demonstrate here that tumor-producing TGF-Β1 induces vascular endothelial growth factor (VEGF) in prostate cancer cells, and hypoxia-inducible factor (HIF)-1α and HIF-2α has opposite functions in TGF-Β1 regulation of VEGF expression under non-hypoxic conditions. The promoter response of VEGF to TGF-Β1 was upregulated by the transfection of HIF-2α or siHIF-1α but downregulated by HIF-1α and siHIF-2α. Both HIF-1α and HIF-2α were induced by TGF-Β1 at mRNA and protein levels, however, their nuclear translocation was differentially regulated by TGF-Β1, suggesting its association with their opposite effects. VEGF induction by TGF-Β1 occurred in a Smad3-dependent manner, and the Smad-binding element 2 (SBE2, 992 to 986) and hypoxia response element (975 to 968) in the VEGF promoter were required for the promoter response to TGF-Β1. Smad3 cooperated with HIF-2α in TGF-Β1 activation of VEGF transcription and Smad3 binding to the SBE2 site was greatly impaired by knockdown of HIF-2α expression. Moreover, the VEGF promoter response to TGF-Β1 was synergistically elevated by co-transfection of Smad3 and HIF-2α but attenuated by HIF-1α in a dose-dependent manner. Additionally, TGF-Β1 was found to increase the stability of VEGF transcript by facilitating the cytoplasmic translocation of a RNA-stabilizing factor HuR. Collectively, our data show that tumor-producing TGF-Β1 induces VEGF at the both transcription and post-transcriptional levels through multiple routes including Smad3, HIF-2α and HuR. This study thus suggests that autocrine TGF-Β1 production may contribute to tumor angiogenesis via HIF-2α signaling under non-hypoxic conditions, providing a selective growth advantage for prostate tumor cells.

KW - HIF-2α

KW - HuR

KW - prostate cancer

KW - Smad3

KW - TGF-β1

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=79952534509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952534509&partnerID=8YFLogxK

U2 - 10.1038/onc.2010.498

DO - 10.1038/onc.2010.498

M3 - Article

C2 - 21057546

AN - SCOPUS:79952534509

VL - 30

SP - 1213

EP - 1228

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 10

ER -